Australia's Jatcorp soars on plans to export infant formula to U.S.
** Shares of consumer goods maker Jatcorp JAT.AX jump as
much as 6.3% to A$0.017
** Says it is working with Austrade, an Australian govt
agency, to provide its infant formula labelling information for
U.S. FDA approval urn:newsml:reuters.com:*:nASX3xT1Jw
** Announcement comes amid increased focus on infant formula
shortage in United States
** JAT up 6.7% YTD as of last close
(Reporting by Harshita Swaminathan)
((Harshita.Swaminathan@thomsonreuters.com))
Recent news on Jatcorp
See all newsBrief: Jatcorp Posts Third Quarter Revenue From Operations Of A$8.97 Million
Brief: Jatcorp Logs Qtrly Revenue From Operations A$12.38 Million
Brief: Jatcorp Ltd To Raise A$4.2 Million At A$0.15 Per Share
Brief: Jatcorp CEO Sunny Liang Resigns
Brief: Jatcorp's Revenue From Ongoing Ops Reaches A$11.5 Million In Quarter